News

News

March 12-15 - DCAT WEEK 2012
Icrom is pleased to announce that will be attending the DCAT WEEK 2012 in New York. Icrom customers and partners are invited to book for a meeting at Icrom Suite in Affinia 50 Hotel (155 East 50th Street; Tel: 212.751.5710 ¦ Fax: 212.753.1468). Please write at morosini@icrom.com to reserve your time slot. We look forward very much to meeting with you in Manhattan!

Oct 25th, 2011 - ICROM AT CPhI WW 2011

Icrom will be at the CPhI WorldWide 2011 edition (Frankfurt) from October 25th to the 27th. Please book for a meeting at: info@icrom.com .

Oct 1st 2011 - Icrom on ICP-Rivista dell'Industria Chimica
Click here to open the article

Aug 5th 2011 - Icrom is the official supplier of Metoclopramide HCl to US Pharmacopeia
We are proud to announce that Icrom has participated to USP Reference Standards Program for Metoclopramide HCl and the quality of our material has passed the checks of the American insistution. Then Icrom is now we USP official supplier of Metoclopramide HCl reference substance since our standard manufacturing quality of this API correponds to the USP reference substance. Click here to view the letter from USP.

Jan26th, 2011 - FDA APPROVAL

We are very proud to announce you that, following the inspection to our Concorezzo (Italy) manufacturing site performed by the FDA auditors last September 2010, our facility has been judged “acceptable” by the United States Food & Drug Administration. This is a pivotal milestone of our marketing expansion efforts towards the pharmaceutical North American market and we are particularly pleased to receiving this qualification just a few weeks before our attendance of this year DCAT Week in New York, which is going to be a fundamental edition for our company.

Jan 5th, 2011 - ICROM AT DCAT WEEK 2011

Icrom will be at the DCAT 2011 Week (New York) from March 14th to the 18th. Icrom suite is at Best Western Hospitality House 145 East 49th Street (Tel. +1-212-753-8781). Please book for a meeting at: info@icrom.com .

Jul 30th, 2010 – NEW HIGH-POTENCY API MANUFACTURING UNIT

Icrom is pleased to inform his customers and partners that the first High-Potency manufacturing unit has just been completed and qualified. This state-of-the-art unit has been aptly conceived for the GMP manufacturing and handling of potent compound down to an OEL of 0.1 ug/m3 on a scale ranging from 10 to 200 g per batch. In the next few months, Icrom will deploy this unit for the validation of chemical processes leading to new generic anticancer api's whose technology has been already set-up and optimised in its own R&D Department.